Benoît Adelus


Benoît Adelus joined ArchiMed in 2018. He has over 30 years of experience within the Animal Health / Medtech / IVD (In Vitro Diagnostics) sectors in senior leadership roles across different geographies. Prior to joining ArchiMed, Benoît led, as CEO, the respective public stock listings of bioMérieux and Sebia. Prior to that, Benoit served as COO at Merial, the animal pharma and vaccine leader.

He successfully managed three LBOs as CEO of Sebia, and oversaw two more through his Chairman position at St Hubert and Arkopharma.

Benoît has a long-standing relationship with the ArchiMed team, through his non-executive Directorships at Carso and Medistream / Citieffe.

Benoît graduated with a doctorate in Veterinary Medicine from the Ecole Nationale Vétérinaire de Nantes and holds an MBA from HEC. He speaks fluent English.